Form4insider filings, from the source

SEC Form 4 · accession 0000932440-16-000485

EAGLE PHARMACEUTICALS, INC. · EGRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jay Moorin
10% Owner
Period of report
Sep 21, 2016
Accepted (ET)
Sep 23, 2016 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock $0.001 par valueF3,F1Sep 21, 2016S97,149$66.15D4,475,785IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF4,F1Sep 21, 2016S1,798$67.24D4,473,987IBy ProQuest Investments IV, L.P.
Common Stock $0.001 par valueF2Sep 21, 2016S194$66.17D8,777IBy ProQuest Financial LLC
Common Stock $0.001 par valueSep 21, 2016S654$66.17D29,574IBy Jay Moorin through IRA

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses